Fundraising Fox
🦊/People
Sign in

Ken MacLeod

Investor

Partner at Rosetta Capital Ltd.

London, England, United Kingdom

Find your path to Ken

266 people in our graph share verified history with Ken — schools, employers, funds. One of them is your warm intro.

Victoria TaylorunlockedKen: together at SV Health Investors
×3Ken: together at Aston University
Ken: together at Serono
×5Ken: together at University of York

About

Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Experience

  1. ROSETTA CAPITAL LIMITEDPartnercurrent2021 — present
  2. JenaValve Technology, Inc.Non Executive Directorcurrent2023 — presentIrvine, California, United States
  3. OxularNon Executive Director2023 — 2024Oxford, England, United Kingdom
  4. Sequana Medical NVNon Executive Director2023 — 2024Ghent, Flemish Region, Belgium
  5. Agate Strategic Advisors LtdManaging Director2016 — 2021
  6. Phase III Development Company SARLDirector2009 — 2017Luxembourg
  7. Visium Asset UK LLP; Visium Healthcare Partners FundManaging Partner2013 — 2016London, United Kingdom & New York, USA
  8. On-X Life Technologies, IncDirector2012 — 2016Austin, Texas, USA
  9. Paul Capital Advisors LLCPartner2004 — 2013London, New York & San Francisco
  10. Paul Capital Advisors (UK) LtdChief Executive Officer2004 — 2013London Area, United Kingdom
  11. SpePharm Holding BVDirector2008 — 2012The Randstad, Netherlands
  12. Pharming Group N.V.Director2006 — 2010Leiden, Netherlands
  13. SV Health InvestorsVenture Partner2001 — 2003London Area, United Kingdom
  14. SeronoVP Northern Europe1998 — 2001
  15. Abbott LaboratoriesDivision Director1988 — 1998

Skills & more

Business Strategy3Biotechnology3Venture Capital12Due Diligence8Valuation3Start-ups2Corporate Development4Private Equity10Entrepreneurship2Corporate Finance2Lifesciences1Mergers1
+6 moreInvestmentsMergers & AcquisitionsTechnology TransferStrategyCommercializationLife Sciences

From Ken's professional profile.

Investments

Board seats

JenaValve Technologies, inc.On-X Life Technologies, Inc.Oxular LimitedPharming Group N.V.SpePharm Holding B.V.

Per the firm's website.

Colleagues at Rosetta Capital Ltd.

Donovan Leung
Investment Manager at Rosetta Capital Ltd.
Graham Fagg
Partner Emeritus at Rosetta Capital Ltd.
Jonathan Hepple
Managing Partner at Rosetta Capital Ltd.
Matthew James
Chief Financial Officer at Rosetta Capital Ltd.
Michael Forer
Partner at Rosetta Capital Ltd.
Namrata Turaga
Investment Manager at Rosetta Capital Ltd.
Torsten Goesch
Director at Rosetta Capital Ltd.

Frequently asked questions

Who is Ken MacLeod?
Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
Where does Ken MacLeod work?
Ken MacLeod is Partner at Rosetta Capital Ltd..
What does Ken MacLeod invest in?
Ken MacLeod invests in Biotech, Healthtech, Medical Devices.
What boards does Ken MacLeod sit on?
Ken MacLeod holds tracked board seats at JenaValve Technologies, inc., On-X Life Technologies, Inc., Oxular Limited, Pharming Group N.V., SpePharm Holding B.V..
Where did Ken MacLeod go to school?
Ken MacLeod studied at University of York (DPhil, Biology); The University of Manchester (BSc, Biology); Aston University (Biology).

Same school

Shared employers